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“The true sign of maturity and excellence in a university is its ability to 
contribute to the knowledge of mankind, in its own society and beyond.”
Those words were spoken by AKU’s founder and Chancellor, His 
Highness the Aga Khan, at our 2003 convocation. Seventeen years 
later – and in the midst of the COVID-19 pandemic – how does the 
University measure against the standard he articulated? Certainly AKU 
is generating far more knowledge today than ever before. Between 
2015 and 2019, the number of research papers published by our faculty 
in peer-reviewed journals increased by more than 50 per cent. And 
our research productivity continued to increase through the first three 
quarters of 2020. We can also take pride in the fact that much of our 
work has been funded by or carried out in collaboration with globally 
renowned institutions such as the Bill & Melinda Gates Foundation, 
the World Health Organization, the University of Washington and the 
University of California, San Francisco.
Yet output data alone cannot capture the impact of our research 
and innovation on people’s lives. As the following pages make clear, 
numerous people across Asia and Africa are benefitting from our 
investigations. As of this writing, COVID-19 has infected nearly 60 million 
people and killed almost 1.4 million globally. AKU is working to deliver 
crucial insights into the novel coronavirus, and is participating in an 
array of international clinical trials to identify vaccines, treatments and 
tests that can help to halt the pandemic. Our researchers are also at the 
forefront of efforts to address an unprecedented outbreak of HIV/AIDS 
among children in Pakistan, to understand the biology of malnutrition, to 
identify emerging viruses and to help East Africa’s news media thrive in 
the digital age. In addition, they are producing cutting-edge scholarship 
in the humanities and social sciences that can help us to understand 
how centuries of cross-cultural interaction have shaped present-day 
identities. 
In short, in keeping with our Chancellor’s vision, AKU is making 
important contributions to humanity’s storehouse of knowledge – 
contributions that are saving and changing lives, especially in low-
income and marginalised communities. 
But with the world facing its gravest public health crisis in recent 
memory, much remains to be done, and we cannot stand still. We must 
recognise that knowledge is constantly evolving, and that expanding the 
frontiers of understanding requires a spirit of restless inquiry. Therefore 
we will continue to strive to fulfill AKU’s potential as a research university, 
and to demonstrate the maturity and excellence our Chancellor intended. 
Firoz Rasul
President and Chief 
Executive Officer
President’s message Message from the academy
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It is our pleasure to report that AKU’s research continues to attract 
increasing support from a wide range of partners and funders located 
both within the countries we serve and in Europe and North America. 
The number of extramural grants the University received in 2019 
represents an all-time high, and a nearly 50 per cent increase from just 
a few years ago. Meanwhile, the value of grants received in 2019 is 
2.5 times higher than the figure five years ago. In total, the University 
attracted more than US$ 150 million in research funding in 2015-2019. 
As 2020 began, we were looking forward to seeing these figures grow 
– and with them, AKU’s contributions to addressing major challenges 
in a wide range of fields and in varying geographies. And despite the 
turmoil created by the COVID-19 pandemic, we are on track to attract 
more research funding in 2020 than in the previous year. Our largest 
grant, amounting to more than US$ 6 million, came from Gavi, the 
Vaccine Alliance, and is supporting research to assess the impact of the 
introduction of typhoid conjugate vaccine in Pakistan. In a year defined 
by the pandemic, almost one-third of all grants the University submitted 
were related to research on the novel coronavirus. This reflects AKU’s 
health-related research prowess, but it also demonstrates our ability to 
rapidly pivot to address important new problems. Meanwhile, 2020 has 
been an especially productive year for our scholars outside the health 
sciences: though the year is not yet over at the time of this writing, AKU 
faculty have already published more peer-reviewed papers in the social 
sciences in 2020 than in all of 2019. 
We are deeply grateful to all those who have supported AKU’s research 
efforts over the past year, including our institutional funders, individual 
donors, alumni, former staff and volunteers. And we wish to thank all our 
faculty and staff, who worked so hard and overcame so many obstacles 
to ensure that the University could continue to deliver innovative new 
research and scholarship amid challenging circumstances. 
Dr Carl Amrhein, Provost and Vice President, Academic
Professor Anjum Halai, Vice Provost and Dean, Faculty of Arts and 
Sciences
Professor Fauziah Rabbani, Associate Vice Provost, Research
Dr Alex Awiti, Vice Provost, East Africa
AKU RESEARCH
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The world has not seen an upheaval 
like the COVID-19 pandemic since 
the great influenza pandemic of 1918-
1919. In the 11 months since the first 
few cases were detected in a localised 
outbreak in Wuhan, China, the novel 
coronavirus has spread to every country 
on earth and affected countless people.  
 
Pakistan and Afghanistan were 
exposed to COVID-19 very early 
through pilgrims returning from Iran. 
Shortly thereafter, East Africa received 
travelers from Europe with the virus. 
Notwithstanding preventive measures 
and stringent official strategies, 
community transmission ensued.
In all geographies, the Aga Khan 
University’s hospitals, health centres 
and laboratories had to rapidly 
transform to deal with a highly infectious 
illness and its consequences. This 
had to be done with staff and patient 
safety in mind, often amidst huge 
personal risks and difficulties in safe 
travel and transportation. Patient 
care had to shift to standards of care 
and personal protection hitherto 
unseen, and consultations had to 
move to virtual platforms, requiring 
a major shift to deliver secure and 
effective communications. Meanwhile, 
faculty launched a massive effort to 
begin teaching students online.
The whole University family stood 
as one, with thousands of faculty 
and staff members making the 
personal sacrifices needed to mount 
an exemplary response. AKU’s 
performance in such circumstances 
is a testament to the resilience of our 
greatest asset: our human resources.  
 
In ordinary circumstances, research 
and scholarship would take a back 
seat to the daily challenge of clinical 
services and survival. Not so at AKU. 
The University developed one of the 
first online courses designed to rapidly 
increase capacity for the provision 
of quality clinical care in intensive 
care settings. It also developed a 
widely recognised mobile-phone 
app to rapidly screen and triage 
suspected cases of COVID-19.
Faculty and students quickly 
pivoted, launching research efforts 
to address a range of challenges of 
immediate concern, such as basic 
epidemiology, risk-factor identification 
for prognosis and sophisticated 
sero-epidemiology studies to assess 
population immunity. Many of these 
competitive research projects were 
nationally or internationally funded, 
and many were collaborations with 
other researchers and institutions.  
 
AKU also rapidly responded to 
government requests for advice in 
each of its key geographies, and 
participated in major global trials 
of therapeutic agents, including 
the Unity and Solidarity trials.
Faculty members undertook in-depth 
evaluations of the direct and indirect 
effects of COVID-19 on the health 
and nutrition of women and children 
in South Asia, and also undertook 
an in-depth assessment of the 
epidemiological burden of disease 
in the Muslim world. Other projects 
are ongoing to assess mitigation 
strategies and efforts to rebuild 
resilience within health systems.  
 
AKU faculty, staff and students 
have withstood the first wave of an 
unprecedented global challenge 
with aplomb, applying evidence-
informed policies and pragmatically 
adapting to local realities.
The financial challenges that are 
inevitable in any organisation were 
met with a unique, equity-focused 
sharing of the burden. As we 
recover from this unique crisis, the 
research enterprise will move back 
to prioritising issues that have taken 
a back seat during the crisis. But we 
will not forget the lessons we have 
learned, and AKU will continue to 
address the challenges created by 
a once-in-a-century pandemic.  
 
Professor Zulfiqar Bhutta 
Founding Director, AKU Institute for 
Global Health and Development 
The AKU family stood 
as one, with faculty 
and staff making 
personal sacrifices to 
mount an exemplary 
response.
Rising to an 
unprecedented 
challenge 
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fix. In the short-term, the only solution 
is a vaccine, which prevents people 
from catching typhoid in the first place.
“The vaccine represents the most 
cost-effective and rapid approach to 
preventing new cases of typhoid,” 
said Associate Professor Farah Naz 
Qamar, principal investigator of the 
study, which is being funded by Gavi, 
an alliance of international organisations 
that works to increase vaccination 
rates, especially in poor countries.
To determine whether the vaccine has 
had an impact on antibiotic resistance 
and has helped decrease the number 
of typhoid cases, the study will analyse 
data on cases from hospitals across 
Sindh and Punjab over the three years 
prior to the vaccine’s introduction, 
comparing it to data on cases that have 
emerged up to three years after the 
launch of the immunisation campaign. 
Researchers are also following a 
group of children who have received 
the vaccine to assess the duration 
of their immune response following 
administration of a single dose of 
the typhoid conjugate vaccine.  
The study is expected to inform 
decisions on whether booster shots 
are needed to provide better and 
longer-lasting protection against 
the disease. The evaluation of the 
impact of the vaccine will provide 
crucial information for policymakers 
in other typhoid-endemic countries 
like Bangladesh and Nepal, which are 
considering introducing the vaccine.
Dr Qamar’s co-investigators at 
AKU are Assistant Professor Sonia 
Qureshi, Assistant Professor 
Momin Kazi, Associate Professor 
Seema Irfan, Senior Instructor Tahir 
Yousafzai and Professor Asad Ali.
AKU played a crucial role in addressing 
an outbreak of extensively drug-resistant 
typhoid in Sindh, and contributed to 
Pakistan’s decision to become the 
first country in the world to use a new 
typhoid vaccine on a routine basis.
Now the University is conducting the 
world’s first evaluation of the impact 
of the typhoid conjugate vaccine in a 
routine immunisation programme. 
Caused by the bacterium Salmonella 
typhi and characterised by symptoms 
including fever and diarrhoea, typhoid 
afflicts 14 million people and kills roughly 
220,000 every year, typically in poor 
communities in Asia and Africa that 
lack access to safe drinking water. 
As the bacterium evolves to become 
extensively drug-resistant, it becomes 
an even greater threat because the 
risk of complications increases and 
treatment grows more difficult and 
expensive. Improved water and 
sanitation facilities play a key role in 
preventing new cases of typhoid, but 
they represent an expensive, long-term 
AKU’s typhoid 
vaccine study is first 
of its kind globally
Amid an outbreak of drug-resistant 
typhoid, researchers evaluate the 
effectiveness of a new vaccine
Increasing resistance
to a range of antibiotics
is making it more
difficult and expensive
to treat typhoid.
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Education Minister Shafqat Mahmood 
to AKU-EB Director Dr Shehzad Jeeva, 
who is also the chairman of the Inter 
Board Committee of Chairmen (IBCC), 
Federal Ministry of Education and 
Professional Training. Pakistan has 33 
examination boards, each of which 
has the power to set examination 
policy. The IBCC exists to enable 
coordination among exam boards. 
 
“The continuity of education of more 
than 4 million students across Pakistan 
was at stake,” Dr Jeeva said. “We were 
asked to create an evidence-based 
approach that could be uniformly 
applied by the country’s examination 
boards to prevent further disruption 
to students’ education. The goal was 
a solution based on the principles 
of fairness, equality and merit.”  
 
AKU-EB’s assessment and operations 
teams studied data on the exam 
performance of 1 million students in 
grades 9-12 over four years. Their 
predictive psychometric statistical 
analysis showed that for SSC 
qualifications (grades 9 and 10), the 
performance of grade 9 students in 
2019 could be used to predict how they 
would have performed on the grade 10 
exams cancelled in 2020. Similarly, for 
HSSC qualifications (grades 11 and 12), 
the performance of grade 11 students in 
2019 could be used to predict how they 
would have performed on the grade 12 
exams cancelled in 2020. In addition, 
there was strong statistical evidence 
that grade 10 and 12 students typically 
improve their performance by 3 per 
cent compared to their grade 9 and 11 
scores. Therefore, it was recommended 
that an additional 3 per cent be added 
to scores of grade 10 and 12 students. 
 
AKU-EB’s recommendation was 
unanimously approved by all relevant 
government agencies, including the 
Higher Education Commission; the 
coordinating body of all the country’s 
education ministers, the Inter Provincial 
Education Ministers Conference; and 
the federal body that brings together all 
AKU research informs 
national examination 
policy during 
COVID-19 disruption  
Policymakers turned to AKU’s Examination
Board when high-stakes exams were cancelled 
government departments to coordinate 
COVID-19 response, the National 
Command and Operation Centre.
The policy was rolled out across 
the nation in September 2020 and 
used to award exam scores and 
promote students across Pakistan. 
 
AKU-EB's technical expertise and 
leadership role in building support 
for a coordinated, transparent and 
fair solution that allowed the nation’s 
students to continue their education 
were acknowledged by Federal 
Education Minister Mahmood. 
 
“The Federal Minister of Education was 
delighted with the outcome and to see 
a national-level policy recommendation 
receive such unanimous support,” 
Dr Jeeva said. “Other nations have 
struggled with controversies over results 
and promotion. The absence of these 
issues, including no reports of litigation 
in Pakistan, speaks to the strength of 
the evidence we were able to marshal.” 
Around the world, the COVID-19 
pandemic has caused the cancellation 
of standardised examinations 
used for university admissions and 
promotion to higher grades, leading 
countries to adopt different methods 
for dealing with the consequences.  
 
In Pakistan, the Aga Khan University 
Examination Board (AKU-EB) played 
a key role in formulating an evidence-
based national policy used to address 
the fact that Secondary School 
Certificate (SSC) exams and Higher 
Secondary School Certificate (HSCC) 
exams were cancelled in order to limit 
the spread of the virus. SSC exams 
are taken in 9th and 10th grades 
and students’ scores are considered 
in admissions decisions by higher 
secondary schools. HSSC exams are 
taken in 11th and 12th grades and 
students’ scores are considered in 
university admissions decisions.  
 
The Board’s involvement was the result 
of a request for assistance from Federal 
High-stakes exams, 
like the one shown in 
this pre-pandemic 
photo, did not take 
place in Pakistan in 
2020 due to COVID-19.
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A pair of studies by AKU’s Graduate 
School of Media and Communications 
(GSMC) in Nairobi aims to help East 
Africa’s news media navigate the 
changes brought by the internet, 
mobile phones and social media. 
While the rise of digital media has 
wreaked havoc on older news 
organisations in many countries, the 
situation in East Africa has been less 
dire. For example, prior to the COVID-19 
pandemic, Kenyan newspaper revenues 
had been growing modestly, and Kenya 
was one of just four countries in the 
world where newspaper revenues were 
expected to continue increasing over 
the next five years, according to a report 
by PricewaterhouseCoopers. Moreover, 
trust in news organisations in Kenya 
remains high by global standards.
Nevertheless, change is happening, and 
rapidly. Since 2014, radio’s audience 
share in Kenya has plunged, although it 
remains the number one news source, 
according to a report by Reelforge and 
TIFA Research. Meanwhile, with internet 
subscriptions having nearly tripled in 
five years, the percentage of people 
who get their news online via their 
mobile phones has greatly increased.
GSMC’s State of the Media Report aims 
to be the most detailed publication 
of its kind, providing information 
on news organisations’ audiences, 
finances and influence; professional 
and industry organisations; the legal 
and regulatory framework in which 
the media operates; the education 
and training of media professionals; 
and notable developments. 
It will initially cover Kenya, but 
will eventually expand to cover 
neighbouring countries. 
The School’s Innovation for Media 
Viability Study will deliver insights 
that East African media organisations 
can use as they seek to achieve 
commercial success and deliver high-
quality content in the digital age.
Researchers will conduct an online 
survey of journalists and executives at 
nearly 450 news organisations, as well 
as follow-up interviews. They will collect 
information on everything from the 
political challenges facing media outlets 
to examples of successful innovation 
with the potential for wider adoption. 
Both projects are funded by KfW, the 
German development bank. The media 
viability study is being conducted in 
partnership with DW Akademie, the 
international media development 
division of Deutsche Welle, Germany’s 
public international news agency.
Studies will help 
East African news 
media navigate the 
digital age
AKU will highlight examples 
of successful innovation by the 
region’s media outlets
The tripling of internet 
subscriptions has 
greatly increased the 
percentage of people 
who get news via their 
mobile phones.
Archaeological studies shed 
new light on the cultural 
heritage of the region
Uncovering the  
history of East Africa’s 
Swahili Coast
15
An expert in Islamic archaeology, 
Professor Stephane Pradines is 
delivering new insights into the 
history of the Swahili, the Indian 
Ocean and the Muslim world.
Prior to joining AKU’s Institute for the 
Study of Muslim Civilisations in London 
in 2012, Pradines spent a decade at 
the French Institute in Cairo leading 
major excavations of the walls that 
surrounded the city during the Fatimid 
era. But his interest in the hundreds 
of ruins that dot coastal East Africa, 
and that date from the 11th century 
onwards, is longstanding. Those 
ruins are the remains of Swahili cities 
that were important nodes in a vast 
trading network that spanned the 
Indian Ocean and connected Africa 
to the heart of the Islamic world, 
as well as to India and China. 
Long before the arrival of European 
explorers, cities such as Mombasa, 
Malindi and Kilwa exported gold, 
ivory, rock crystal and timber to 
the wider world. In return, they 
received ceramics, glass and – most 
consequentially – Islam. Out of these 
exchanges was born the Swahili 
civilisation, a hybrid of African, Arab 
and Indo-Persian influences.
The archaeologists of the Swahili 
coast and adjacent islands has largely 
been shaped by scholars who were 
Africanists by training. Pradines’ 
background gives him a different 
perspective, helping him to see what 
others have overlooked. For example, 
in their excavations of Dembeni, a 
wealthy city on the island of Mayotte 
that thrived from the 9th to the 12th 
centuries, Pradines and his team found 
numerous fragments of rock crystal. 
This translucent form of quartz was 
highly valued in Baghdad, Cairo and 
elsewhere, where craftsmen carved it 
into vases and decorative objects. 
While other archaeologists had noted 
such fragments in Dembeni, they 
speculated they were connected 
to the production of iron ore. But 
with his knowledge of Fatimid and 
Abbasid material culture, Pradines 
quickly recognised the rock crystal 
as such. He argues it was brought 
from Madagascar to Dembeni, where 
it was traded for ceramics and other 
items before being shipped onward to 
the Middle East. Indeed, he suggests 
the rock crystal trade could be the 
source of much of Dembeni’s wealth.
Dembeni is far from the only African 
site where Pradines has conducted 
excavations, having worked on 
a number of well-known ruins in 
Kenya and Tanzania, including Kilwa 
Kisiwani, site of the largest medieval-
era mosque in Sub-Saharan Africa. 
He has spent many days living in 
a tent on a beach with no running 
water, fending off mosquitoes and 
hacking away at vegetation to 
expose centuries-old stone ruins.  
Pradines’ latest project is on the Mafia 
archipelago off Tanzania. There, he is 
working with the World Monuments 
Fund to preserve the ruins of Kua, a 
medieval Swahili town, and to enable 
them to be safely developed as a 
tourist site that benefits the island’s 
residents. Eventually, he hopes to see 
Kua included on the World Heritage List. 
Swahili cities were 
important nodes in a vast 
trading network connecting 
Africa to the Islamic world, 
India and China.
AKU will be working to identify, 
understand and prevent potential 
pandemic viruses as part of a globe-
spanning partnership supported by 
a five-year, US$ 8.75 million grant 
from the U.S. National Institutes of 
Health’s Centers for Research in 
Emerging Infectious Diseases.
Led by the University of Washington 
(USA), the UWARN partnership 
includes Rockefeller University (USA), 
FIOCRUZ (Brazil), IRESSEF (Senegal), 
KRISP (South Africa) and Chang Gung 
University (Taiwan), as well as AKU.
The centres will work to establish 
surveillance networks that can 
identify disease outbreaks at an early 
stage; develop tools for diagnosing 
emerging and re-emerging infectious 
diseases; and study the genetic make-
up of viruses, as well as the body’s 
immune response to viral diseases.
“Partners in the network will be 
constantly on the lookout for emerging 
viruses,” said AKU Associate Professor 
Najeeha Talat Iqbal, the project’s 
principal investigator in Pakistan. 
“When we find them, our goal will be 
to increase our knowledge of how they 
affect the body so that we can improve 
our recognition of signs of severe 
disease and develop therapies that 
can improve treatment outcomes.” 
Pakistan is a hotspot for vector-borne 
illnesses and has seen four outbreaks 
of infectious diseases, other than 
COVID-19, over the past decade. 
AKU will use its countrywide  
network of laboratories to collect 
samples of emerging viruses for 
genetic analysis and enrol hospital 
patients in studies to monitor 
their response to treatment.  
Public health researchers, basic 
scientists, infectious disease 
specialists and pathologists at AKU 
will be involved in the study. 
Dr Iqbal’s co-investigators are 
Associate Professor Farah Qamar, 
Assistant Professor Ali Faisal 
and Professor Erum Khan.
AKU joins international 
network to identify and 
analyse new viruses
Viruses know no boundaries. AKU 
is part of a global effort to identify 
emerging outbreaks
University of Washington 
Seattle, USA Rockefeller University
New York City, USA
FIOCRUZ
Rio De Janeiro, Brazil
IRESSEF
Dakar, Senegal
Aga Khan University
Karachi, Pakistan
Chang Gung
University
Taipei, Taiwan
KRISP
Durban, 
South Africa
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Dr Ali is also testing a new device 
in partnership with Professor Gary 
Tearney of Harvard Medical School. 
It promises to give the first-ever 
insights into the gut health of pregnant 
women. Those insights could be used 
to improve the health and nutritional 
status of both pregnant women 
AKU researchers are conducting 
pioneering research into the causes of 
malnutrition and its inter-generational 
consequences, in partnership 
with faculty at the University of 
Virginia and imaging specialists at 
Massachusetts General Hospital, an 
affiliate of Harvard Medical School.
Environmental enteric dysfunction 
(EED) – often referred to as a neglected 
disease of poverty – is thought to be 
a leading cause of stunting in children 
in the developing world. EED hinders 
the gut’s ability to absorb essential 
nutrients, compromising children’s 
growth and leaving them vulnerable to a 
range of diseases. It is thought to be the 
result of chronic inflammation owing to 
continuous oral exposure to fecal matter 
and their babies, as malnourished 
mothers are much more likely to give 
birth to malnourished children. 
Until now, assessing the gut health of 
expecting mothers was not possible 
because it was not possible to perform 
gut biopsies due to the risks involved 
in administering anaesthesia during 
pregnancy. Researchers will test a 
new trans-nasal scope that does not 
require patients to be anaesthetised. 
It consists of a slender tube that can 
be moved down the nose, through the 
throat to the gut. The tube contains a 
camera, a device that sends electrical 
pulses through the intestine to assess 
nutrient absorption capacity, a brush to 
collect tissue samples and cryobiopsy 
technology that freezes samples 
through contaminated food and water 
in communities that lack clean water.  
With funding from the Bill & Melinda 
Gates Foundation, Professor 
Asad Ali is working alongside 
University of Virginia Assistant 
Professor Sana Syed to harness 
the power of artificial intelligence 
to uncover patterns in biopsies of 
malnourished children’s guts. 
Software the researchers developed 
uses the same principles as facial 
recognition technology to compare 
images of healthy intestines to 
those affected with EED.
The software learns to recognise
patterns as it analyses more
Novel insights 
into gut health 
and stunting 
in children 
to preserve them for analysis. The 
scope will be piloted on 150 pregnant 
women in the U.S. and Pakistan. 
Part of the trial will be conducted at 
AKU’s Matiari Research and Training 
Centre, which is located in an area 
where malnutrition is common, and 
where the University has earned the 
trust of residents over many years. 
“Our ultimate goal is to take this 
technology to the doorsteps of the 
malnourished,” Dr Ali said. “This 
will enable us to easily assess the 
severity of malnutrition in women and 
children living in high-risk areas. In 
the long term, we hope to use this to 
test the success of different nutrition 
interventions by capturing before and 
after images of an individual’s intestine.” 
images and eventually should be
able to pinpoint the cellular-level
differences that trigger the disorder.
Dr Ali and Dr Syed believe their work 
will generate insights that transform 
how doctors diagnose EED. At present, 
the only way to conclusively identify the 
disease is through a biopsy, an invasive 
and expensive procedure that requires 
sedating children in order to extract 
tissue samples from their intestines. 
Their goal is to identify a comprehensive 
set of screening biomarkers – chemical 
warning signs – that would enable 
clinicians to diagnose EED through a 
simple blood or urine test, and that 
could also be used to assess nutritional 
or pharmacological interventions aimed 
at reducing the effects of the disease.
Partnerships with U.S. 
universities enable pioneering 
work in artificial intelligence 
and diagnostics
The goal is to identify 
a comprehensive set of 
screening biomarkers 
that enable clinicians 
to diagnose EED 
through a simple 
blood or urine test.
Educating parents on 
the power of play in early 
childhood development
Providing children with a stimulating 
environment in their earliest years can 
benefit them throughout their lives
23
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AKU’s Institute for Human Development 
(IHD) is conducting a study designed 
to furnish information that can be 
used to expand programmes that 
encourage parents to play and 
communicate with their young children 
in ways that promote their intellectual, 
emotional and social development.   
UNICEF’s Care for Child Development 
(CCD) intervention package encourages 
“playful parenting” – an approach 
that sees parents communicate with 
their children even before they are 
able to speak, play developmentally 
appropriate games with them and 
encourage their questions and curiosity.
Under the Scaling Up Playful Parenting 
(SUPP) project, faculty will produce case 
studies of Care for Child Development 
programmes in Kenya, Tanzania, 
Uganda and Syria. The studies will be 
based on focus group discussions and 
individual interviews. Researchers will 
also examine how CCD programmes 
can be adapted to meet the needs of 
parents and children in areas affected 
by conflict or a high burden of HIV/AIDS.
Preliminary investigations have revealed 
the existence of  a wide range of 
standalone CCD programmes that 
are not integrated into government 
schemes and tend to be short-lived.
“Early childhood development 
interventions such as Care for Child 
Development represent one of the best 
ways to build strong, prosperous and 
stable societies,” said IHD Director 
Amina Abubakar. “The findings of 
our study will help policymakers 
and practitioners to determine how 
best to go about educating parents 
on caregiving approaches that help 
children to fulfill their potential.”
As part of the project, IHD is identifying 
individual programmes’ gaps and 
resource requirements, with a view 
to conducting capacity-building 
sessions for programme staff. 
IHD’s capacity-building 
experience in East Africa includes 
trainings on the Science of Early 
Childhood Development.
 
IHD will also help universities in 
Kenya and Zambia to integrate playful 
parenting and key child development 
topics into degree and professional 
development programmes.
In addition, the Institute plans to build 
an online hub for early childhood 
development that enhances access to 
technical resources and experts, thereby 
empowering practitioners to scale up 
initiatives wherever they may be.
SUPP is funded by UNICEF, 
the Lego Foundation and the 
Aga Khan Foundation. 
AKU plans to build an 
online hub for early 
childhood development
that enhances access 
to technical resources 
and experts.
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Exposed water systems 
are prone to damage, 
illegal connections, 
contamination and 
freezing. Burying pipes 
helps prevent such 
problems.
Access to clean water and sanitation in 
the Global South is often hampered by 
the failure of governments to develop 
the necessary infrastructure. Even when 
governments do invest in infrastructure, 
it often deteriorates because users 
cannot or will not pay water tariffs.  
Community-based water management 
(CBWM) attempts to solve the 
problem by mobilising community 
members to pay for and operate water 
infrastructure. In the mountainous 
Gilgit-Baltistan region of northern 
Pakistan, the Aga Khan Agency for 
Habitat (AKAH) has introduced CBWM 
in more than 400 rural communities 
totaling 100,000 households, 
through its Water and Sanitation 
Extension Programme (WASEP). 
So far, CBWM appears to have 
worked well in rural areas with 
small and presumably tightly knit 
communities. AKAH is now scaling 
up WASEP to more urban areas in 
the region that have much larger 
and more transient populations 
and different social dynamics.
To determine if scaling-up is feasible, 
AKU’s Institute for the Study of 
Muslim Civilisations (ISMC) in London 
has launched a study of WASEP 
across Gilgit-Baltistan, including 
two large recent urban water 
schemes in Jutial and Danyore. 
The study brings together researchers 
in economics, anthropology, 
geography, the environmental sciences 
and engineering from ISMC and 
Karakoram International University 
(KIU) in Gilgit, as well as engineers 
and development practitioners from 
AKAH. ISMC Associate Professor 
Jeff Tan, an economist who has 
published on water and infrastructure 
privatisation, is the project’s principal 
investigator. Co-investigators are 
ISMC Professor Stephen Lyon and 
Professor Attaullah Shah of KIU.
Evidence for the study will be 
drawn from interviews with 1,200 
households in more than 60 WASEP 
and non-WASEP control sites across 
Gilgit-Baltistan, along with focus 
group discussions, water quality 
testing and engineering audits.
The study focuses on the factors that 
influence the willingness of community 
members to make monetary and 
in-kind contributions to construct 
infrastructure, and to make monthly 
tariff payments. It will examine whether 
successful social mobilisation is 
related to the size of a community, 
wider institutional support, religious 
affiliation, education levels and social 
structures. It will look into sources 
of conflict such as the passage of 
pipes over privately owned land and 
whether issues related to social status 
or sectarianism undermine social 
mobilisation within a community. 
The study will also investigate how local 
terrain affects project management, 
and the extent to which women 
benefit from and contribute to social 
mobilisation and improved health 
and hygiene outcomes. “Sustainable 
water systems are at the heart of 
thriving communities,” Tan said. “This 
study will generate valuable lessons 
on the social, economic, cultural 
and technical factors that govern the 
management of scarce water resources 
and enable local communities 
to improve their livelihoods.”
The research team hopes that the 
lessons learned will be of interest not 
only to AKAH but to the Government of 
Gilgit-Baltistan and actors elsewhere 
in the developing world where access 
to water is a problem. The two-
year project is funded by the British 
Academy’s Urban Infrastructures 
of Well-Being programme. 
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America and 
Islam in the age 
of Trump
Dean Lawrence Pintak’s  
latest book explores America’s 
complex relationship with  
the Muslim world 
An award-winning, globe-trotting 
journalist and an accomplished 
academic with a PhD in Islamic
Studies, Lawrence Pintak became Dean 
of AKU’s Graduate School of Media
and Communications in Nairobi in 
mid-2020. His latest book is America
& Islam: Soundbites, Suicide Bombs
and the Road to Donald Trump. A
finalist for the Religion News 
Association’s Awards for Religion 
Reporting Excellence, America & 
Islam offers a wide-ranging tour
of America, the Muslim world and 
relations between the two in the age
of Trump.
In his opening pages, Pintak
analyses the context in which Trump’s 
Islamophobia found an audience. He
discusses America’s long history of 
Middle East misadventures; the 
media’s willingness to hand Trump 
a megaphone in its quest for ratings 
and profits; the fact that Trump’s 
prejudices were echoed by well known
Republicans; and the rise
of ISIS, which helped to revive 
fears that had slowly dissipated in 
the years after Sept. 11, 2001. 
It was against this backdrop that Trump 
found it possible to assert that “Islam 
hates us,” to conjure the spectre of 
crowds of Arab-Americans cheering 
the collapse of the World Trade Center 
and to call for a ban on Muslims 
entering America. Pintak quotes a 
law professor’s reaction to the Nov. 9 
news of Trump’s election: “For Muslim 
Americans, 11/9 feels like 9/11 all over 
again: the aftermath is frightening.” 
In the latter part of the book, Pintak 
seeks to supply the nuance missing 
from many discussions of Islam and 
extremism. He charts the diversity 
of Muslim belief, chronicles “how 
the West created radical Islam,” and 
clarifies the meaning of key terms 
ranging from Islamism to sharia. Turning 
from religion to politics, he probes 
the rivalry between Saudi Arabia and 
Iran, Turkey’s Ottoman dreams and 
the growth of Russian and Chinese 
influence from Islamabad to Damascus.
Finally, Pintak turns his gaze to 
the future, asking how Muslims’ 
interpretations of their faith might 
change in the years ahead. In Saudi 
Arabia, he sees a “a huge constituency” 
for liberalisation. In Pakistan, he 
interviews artist-activists who aim to 
battle extremism with comic books. 
In Indonesia, he finds widespread 
support for Islam as “a living religion 
receptive to the modern world.” 
Indeed, he finds Muslims “from Lagos 
to Lahore…taking steps, large and 
small, to tame the extremist beast.” 
Returning to America, Pintak finds 
the country’s Muslims living in “an 
era of contradictions. Never had they 
been more under attack, but never 
had they been so accepted and 
outspokenly proud to be American.” 
He concludes on an optimistic note, 
citing a survey that found Americans 
have a more favourable view of Islam 
than ever before. Pintak gives newly 
elected U.S. Rep. Ilhan Omar the last 
word, quoting her defiant response 
to a critic who complained that “the 
floor of Congress is now going to 
look like an Islamic republic.” 
“Well, sir,” Rep. Omar tweeted, 
“the floor of Congress is going 
to look like America…And you’re 
gonna have to just deal [with it].”
AKU has been at the forefront of the 
provincial, national and international 
response to an outbreak of HIV/AIDS 
that infected nearly 1,200 children in 
Larkana District, Sindh. The University 
was the first to alert officials of an 
outbreak, and has been advising 
government, providing patient care 
and training health workers, as well 
as publishing the most in-depth 
study of the outbreak to date, in 
The Lancet Infectious Diseases. 
With funding from the World Health 
Organization, Associate Professor Syed 
Hani Abidi and colleagues studied the 
outbreak using phylogenetic analysis. 
They found that the HIV strains involved 
(known as CRF02_AG and A1) likely 
originated among people who inject 
drugs. Nationally, around 40 per cent of 
adult intravenous drug users have HIV/
AIDS, and Larkana has a significant 
population of people who inject drugs. 
Poor infection control practices in 
health facilities then allowed the strains 
circulating among drug users to be 
transmitted to children. While initial 
media reports implicated a single local 
HIV-positive doctor in the outbreak, 
AKU researchers found multiple 
clusters within the outbreak, indicating 
a number of healthcare facilities 
contributed to the spread of the virus. 
That suggests that poor infection 
prevention practices are widespread. 
Today, 98 per cent of the infected 
children are taking antiretroviral drugs 
and should be able to lead long and 
generally healthy lives. That is partly 
thanks to AKU. University staff assisted 
with screening the population, opening 
a new clinic for HIV-positive children, 
treating hundreds of patients in Larkana 
and training health professionals in 
managing patients with HIV/AIDS. Yet 
much remains to be done, according 
to Associate Professor Fatima Mir, 
lead author of the Lancet article.
“It’s unconscionable that these 
children were infected,” Dr Mir said. 
“The government response to the 
outbreak has been commendable, 
but now we need to see a major effort 
to improve infection control in both 
the public and private sectors.”
Study co-investigators included 
Associate Professor Syed 
Faisal Mahmood and Associate 
Professor Rehana Siddiqui.
 
Poor infection control 
practices in health 
facilities allowed 
strains of the virus to 
move from drug users 
to children.
AKU alerts 
government to 
HIV/AIDS outbreak 
in children 
AKU researchers revealed how the disease 
spread using phylogenetic analysis
AKU’s 
contributions 
to the global battle 
against COVID-19 
The novel coronavirus is the biggest 
challenge facing the world today. In Asia 
and Africa, AKU is at the forefront of 
the effort to better understand the virus 
and its impact, prevent its spread and 
identify new ways to treat the infected. 
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Convalescent plasma therapy
Convalescent plasma therapy uses 
antibodies from individuals who 
have recovered from COVID-19 to 
treat patients who have severe or 
critical forms of the disease. While 
many countries have permitted 
its use, more data on its safety 
and efficacy is still required. 
AKU is part of a Pakistan-based, 
multi-centre clinical trial to evaluate 
the therapy. Antibody-rich plasma from 
recovered COVID-19 patients at the Aga 
Khan University Hospital, Karachi, will 
be used to boost the immune system 
of individuals undergoing treatment at 
the hospital. Researchers will monitor 
each patient’s response and assess 
the therapy’s effectiveness through a 
range of clinical and laboratory tests. 
In both Karachi and Nairobi, AKU 
is contributing to the global effort 
to identify safe and effective 
COVID-19 vaccines, treatments and 
diagnostic tests. Six clinical trials 
are underway or have concluded, 
five of which are international.  
Remdesivir 
The World Health Organization’s 
global Solidarity trial explored the 
potential of four drugs (remdesivir, 
hydroxychloroquine, lopinavir/ritonavir 
and interferon) to treat COVID-19 
in hospitalised adult patients. AKU 
was one of nearly 400 research sites 
around the world chosen to investigate 
whether remdesivir, a drug used to 
treat Ebola, could help prevent deaths 
from the virus or reduce the severity 
of the disease. The trial found all 
four treatments to have little or no 
effect on overall mortality, initiation of 
ventilation or duration of hospital stay.
CanSino and Sanofi vaccines 
As the world races to develop a 
COVID-19 vaccine, AKU is helping 
to evaluate CanSino Biologics’ Ad5-
nCoV vaccine in Pakistan. A phase III 
randomised, double-blind, placebo-
controlled multi-country trial is 
assessing the vaccine’s safety and
immunogenicity (its ability to provoke 
an immune response that protects a 
vaccinated person against COVID-19). 
The vaccine will be administered to 
volunteers over the age of 18 who 
have no history of being infected by 
the virus. Other hospitals in Pakistan 
are part of the trial, which seeks to 
include 8,000-10,000 patients across 
the country. In Kenya, AKU will 
participate in a phase III trial of Sanofi’s 
adjuvanted, recombinant protein-based 
vaccine. The randomised, double-blind, 
placebo-controlled, multi-country trial 
is expected to get underway by the 
end of 2020. Globally, it aims to enroll 
a total of more than 34,000 participants 
over the age of 18, including individuals 
who have been exposed to COVID-19 
and individuals over the age of 65.
  
Clinical trials test 
vaccines, therapeutics 
and more
Hydroxychloroquine
AKU is the only centre in South Asia 
participating in the COPCOV trial, 
which is assessing whether taking 
hydroxychloroquine or chloroquine 
prophylactically prevents healthcare 
workers exposed to COVID-19 
patients from contracting the disease. 
Sponsored by the University of Oxford 
and funded by the Bill & Melinda Gates 
Foundation and other organisations, 
the randomised, double-blind, placebo-
controlled trial has been deemed to be 
of urgent public health importance by 
the UK’s National Institute for Health 
Research’s Clinical Research Network. 
Frontline healthcare workers at AKU are 
currently being enrolled into the trial. 
Rapid antigen test
AKU is the only centre in Asia 
participating in a global, multi-centre 
clinical trial of a potentially quicker 
and more cost-effective COVID-19 
diagnostic test, Abbott’s Panbio rapid 
antigen test. The Panbio test can 
deliver results in as little as 30 minutes, 
compared to 12 hours or more for a 
PCR test. It assesses the reaction of 
a patient specimen to antibodies on a 
testing strip, avoiding the need to send 
samples to a laboratory for processing. 
The faster reporting of results can 
help to limit the spread of the virus. 
“If this test proves to be as accurate 
as existing methods, then we’ll have 
played a part in making available a 
COVID-19 test that is faster and also 
significantly cheaper than existing 
options,” Professor Erum Khan said. 
“That would be good not just for 
Pakistan but for the entire world.” 
Tocilizumab 
AKU’s Clinical Research Unit (CRU) in 
Nairobi was part of a global, phase III 
clinical trial, EMPACTA, which studied 
whether a drug typically used to treat 
rheumatoid arthritis, tocilizumab, 
could safely prevent the onset of 
pneumonia in COVID-19 patients.
Pneumonia is one of COVID-19’s 
most common serious complications, 
with patients often needing a 
ventilator to survive. The randomised, 
double-blind, placebo-controlled 
trial found that patients on the 
drug were 44 per cent less likely to 
require mechanical ventilation or 
lose their lives to the disease.
AKU was the only site in Africa 
outside of South Africa that 
participated in the trial. 
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AKU is contributing to a two-year 
study in Kenya designed to illuminate 
the immune system’s response to 
the novel coronavirus and aid in the 
development of vaccines and therapies. 
“We’re still very far from knowing how 
the immune system protects us from 
the virus,” Associate Professor Shahin 
Sayed said. “It means that we can’t 
explain why some patients recover 
with ease, and this limits our ability to 
predict who needs more aggressive 
treatment and who can be spared the 
toxicity and cost of intensive care.”
Funded by the European and 
Developing Countries Clinical Trial 
Partnership, the study will enrol 400 
individuals from Kenya who have been 
infected with COVID-19. Researchers 
will obtain clinical histories as well as 
blood and nasal swab samples when 
a person is first infected with SARS-
CoV-2. Samples will also be collected at 
regular intervals over a two-year period.
This will enable researchers to assess 
the most important determinants in 
the immune system’s response over 
time. Data will also be correlated 
with the severity of illness to enable 
insights into the interplay between 
the virus and the immune response 
during the course of the illness.
The study promises to deliver insights 
into a range of questions, including 
how long antibodies protect a person, 
how different parts of the immune 
system communicate with one another 
to tackle the virus, which types of 
white blood cells are most effective 
in combating the virus, and what 
explains so-called cytokine storms and 
the respiratory distress they cause.
Researchers will also evaluate the
effectiveness of antibody tests and 
other immunological assays, such 
as blood serum testing (serology), 
for detecting previous infection with 
SARS-CoV-2. As PCR testing is not 
always available and can deliver false 
negatives, mass serological testing 
could be used to determine the number 
of people previously exposed to SARS-
CoV-2 in a given population. That would 
give a clearer picture of the overall 
spread of the virus. Potentially, this 
information could shape governments’ 
COVID-19 management policies. 
Serological tests will also be required for 
evaluating the effectiveness of vaccines. 
In addition, the study will isolate 
monoclonal antibodies from COVID-19 
survivors. These antibodies could help 
inform vaccine design and assist in the 
development of potential therapeutics.
While similar research is ongoing in 
other parts of the world, it is important 
to undertake such studies in Africa, 
where individuals may have concomitant 
infections such as tuberculosis, HIV/
AIDS or malaria. The study aims 
to explore the impact of such co-
morbid conditions on the immune 
system’s response to SARS-CoV-2. 
Led by the KEMRI-Wellcome Trust 
Research Programme, the study involves 
AKU, the Karolinska Institute, Karolinska 
University Hospital, Leiden University 
Medical Centre and Mabtech, a Swedish 
biotechnology company. Kilifi County 
Hospital and the Aga Khan Hospital 
in Mombasa are also participating. 
Associate Professor Reena Shah 
and Professor Mansoor Saleh are 
co-investigators on the study.
AKU’s study will track the 
immune response of 400 
Kenyans
Understanding the 
immune system’s 
response to COVID-19
Researchers will 
explore how co-morbid 
infections affect the 
body’s response to the 
novel coronavirus.
AKU RESEARCH
34 35
AKU RESEARCH
An online survey of Kenyan healthcare 
workers found nearly two-thirds 
may suffer from post-traumatic 
stress disorder, 25 per cent have 
symptoms of moderate to severe 
depression and 40 per cent consume 
harmful amounts of alcohol.
Conducted while COVID-19 was 
circulating in Asia and Europe but had 
yet to reach Kenya, the survey is the 
work of Lukoye Atwoli, Professor of 
Psychiatry and Dean of the Medical 
College, East Africa, as well as faculty 
and staff from Moi Teaching and Referral 
Hospital and Moi University School of 
Medicine. The survey also found that 15 
per cent of respondents had moderate 
to severe anxiety and 20 per cent 
suffered clinically significant insomnia 
or were just below the threshold for 
clinically significant insomnia.
More than 950 healthcare workers 
out of 1,259 contacted filled out the 
survey, which consisted of standardised 
questionnaires such as the World 
Health Organization’s Alcohol Use 
Disorder Identification Test (AUDIT) 
and the PHQ-9 depression test. 
Almost 40 per cent of respondents 
were non-specialist doctors, while 
16 per cent were specialist doctors, 
20 per cent were nurses, 9 per cent 
were clinical officers, and the rest 
represented other health professions. 
Given that Kenyan health workers 
were suffering from a high burden of 
mental distress prior to the arrival of 
COVID-19 in the country, Dr Atwoli and 
his collaborators decided to establish 
a hotline to provide mental health 
support to healthcare workers during 
Study finds stress 
among Kenyan 
health workers
the pandemic. With the assistance 
of various professional associations, 
they established a call centre in the 
headquarters of the National Nurses 
Association of Kenya staffed by clinical 
psychologists and counsellors. 
The centre fielded calls from 30 
healthcare workers in the first month 
of its existence. Data on the hotline’s 
usage is being collected, and the 
researchers plan to conduct a survey 
after one year to gauge its impact. They 
also continue to analyse the responses 
to their initial survey, aiming to identify 
factors associated with mental 
distress among healthcare workers.
Researchers launched a hotline 
so health professionals can get 
counselling
The survey found 
Kenyan health 
personnel were 
suffering from 
depression and other 
mental health issues 
even before the 
pandemic arrived.
Expanding Pakistan’s 
intensive care capacity 
for COVID-19
A nationwide study of critical 
care facilities informs efforts to 
strengthen the healthcare system 
Most intensive care 
units were short of 
infrastructure, trained 
personnel and policies 
for patient care.
A survey of nearly 80 intensive 
care units (ICUs) across Pakistan 
conducted by AKU found that despite 
their success in obtaining beds and 
ventilators during the pandemic, 
many ICUs continue to lack crucial 
infrastructure and personnel. That could 
spell trouble if the country experiences 
a second wave of the COVID-19 
pandemic, or an outbreak of another 
disease that strains ICU capacity. 
“High-tech equipment is only a 
part of what makes a successful 
ICU,” said AKU Associate Professor 
Asad Latif, who led the survey. 
“You also need trained staff, the 
right spaces to treat patients and 
systems to maintain quality.”
The survey reported shortages of 
negative pressure isolation rooms, 
oxygen supplies, nurses and 
qualified critical care physicians. 
Many ICUs also lacked policies 
and protocols for patient care.
Dr Latif and his team consulted 
frameworks for health-systems 
strengthening before designing a 
comprehensive survey to assess 
the quality and scope of facilities, 
staff, equipment and systems 
at ICUs across Pakistan. 
“This survey points out the most critical 
gaps in our intensive care delivery,” 
Dr Latif said. “While investing more 
money in the healthcare system is 
important, we also need to invest 
in building the capacity of staff and 
strengthening processes in order to 
raise the quality of care in our ICUs.”
The assessment is part of the 
University’s broader Tele-ICU initiative. 
Under agreements with the Government 
of Sindh and the federal Ministry of 
Health, and with funding from the Bill 
& Melinda Gates Foundation and the 
Dawood Foundation, AKU is working 
towards building the capacity of 
healthcare workers across the country 
to care for COVID-19 patients.
Over 12,000 people have attended the 
University’s online workshops on the 
use of personal protective equipment, 
and AKU’s courses related to the care 
of COVID-19 patients have attracted 
more than 10,000 participants.
AKU has also established a hotline to 
provide teleconsultations to physicians 
treating COVID-19 patients, particularly 
focusing on government hospitals. To 
date, more than 500 frontline healthcare 
workers have called the hotline and 
consulted with AKU specialists.
At the signing of the agreement 
between AKU and the federal Ministry 
of Health, Dr Zafar Mirza, then the 
Prime Minister’s special assistant 
on health, said the partnership “will 
contribute to the national effort to 
improve recoveries and save lives.”
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the trust of the local community. 
Since approximately 10 per cent of 
the cohort is pregnant at any point in 
time, the AMANHI biobank is likely to 
be a valuable tool in understanding 
how COVID-19 affects maternal 
and child health in the area. 
Researchers will contact women 
enrolled in the study to ascertain 
whether they have experienced 
symptoms of the disease. Samples 
To date, studies have generated 
conflicting findings on how 
COVID-19 affects pregnant women 
and their babies. AKU researchers 
in Nairobi and Karachi aim to 
shed new light on the subject. 
In Nairobi, a team led by Professor 
Marleen Temmerman have been 
engaged in a major study of placental 
disorders (pregnancy hypertension, 
foetal growth restriction, etc.) in 
multiple African countries, using a 
biobank of samples collected from 
women throughout their pregnancy. 
The study, known as PRECISE, has 
now been expanded to investigate the 
impact of the novel coronavirus on 
pregnant women and their babies. 
The team will conduct regular COVID 
testing on more than 1,000 pregnant 
women and 250 non-pregnant women, 
assess outcomes among those infected 
will also be collected from a cohort 
of pregnant women with COVID-19 
until 42 days after birth to ascertain 
the course of the disease through 
pregnancy. COVID-19 antibody 
tests will be conducted on study 
participants to understand the burden of 
COVID-19 and to ascertain the immune 
system’s response to the disease.
Indirect impacts of the pandemic
AKU researchers in Pakistan and 
Kenya are also examining the 
indirect impact of the pandemic 
on mother and child health.
In Pakistan, as part of the AMANHI 
project, researchers will be looking 
to understand how the pandemic 
has impacted nutrition, breastfeeding 
and immunisation of newborns.
Data will be compared with findings 
from other AMANHI countries to 
and collect and analyse biological 
samples to determine whether and 
for how long SARS-CoV-2 is present 
in blood, urine, umbilical cord blood, 
amniotic fluid and other samples, as well 
as determine the presence of antibodies 
in cord blood and breast milk.
Their study involves women in Kenya, 
Uganda, Mozambique, Malawi and 
The Gambia. It will shed light on 
whether women infected with the 
virus are at a greater risk of pre-term 
births or pregnancy complications, 
and how pregnancy affects the 
progression of the disease in women.
“The novel nature of COVID-19 means 
there are many areas where we have 
no answers,” said Dr Temmerman, 
Director of the Centre of Excellence in 
Women and Child Health, East Africa. 
“Our project will be one of the largest 
studies to date of these issues.” 
What is COVID-19’s 
impact on maternal 
and child health?
shed light on the best strategies 
to prevent disruptions to essential 
services during pandemics.
In Kenya, Dr Temmerman and her 
fellow researchers will consult data 
from the Ministry of Health and from 
health facilities in Kilifi, Mombasa and 
Nairobi to assess trends in healthcare 
utilisation. They will also conduct 
interviews with service providers to 
assess the reasons for changes in 
health-seeking behaviour. This will 
aid researchers in understanding 
the pandemic’s impact on antenatal 
and postnatal care, facility deliveries, 
family planning and adolescent health. 
As a member of a Ministry of Health 
working group that is looking at the 
delivery of essential health services 
during the pandemic, Dr Temmerman 
will present the study’s findings to 
decision-makers to inform efforts to 
improve pandemic preparedness.
Dr Temmerman brings to the study 
decades of experience in studying 
HIV/AIDS in pregnant women.
In Pakistan, AKU Associate Professor 
Dr Fyezah Jehan and her team will 
be using the AMANHI biobank to 
understand the spread, severity and 
spectrum of COVID-19 in pregnant 
women and their newborns. The 
AMANHI biobank is part of a World 
Health Organization study of maternal 
and child health outcomes that spans 
eight countries in South Asia and Africa, 
with AKU being responsible for sample 
collection and analysis in Pakistan.
The biobank has enrolled more than 
2,500 women and 2,300 children 
who live in the area of Ibrahim 
Hyderi in Karachi. The University 
has been providing low-cost primary 
care health services in the area for 
a number of years and has earned 
Biorepositories will help researchers 
examine how COVID-19 affects pregnant 
women and their babies
“The novel nature of 
COVID-19 means there 
are many areas where 
we have no answers. 
Our project will be one 
of the largest studies to 
date of these issues.”
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Researchers found very different 
attitudes to the virus in Pakistan 
and Hong Kong
Researching the 
role of genetics  
in SARS-CoV-2
Why hasn’t the virus been more 
deadly in Pakistan? Genetic 
analysis may deliver answers
41% of Pakistanis 
rated COVID-19 
symptoms as being 
severe or very severe, 
versus 97% of Hong 
Kong residents.
Pakistan continues to experience 
a relatively low death rate from 
COVID-19 and a high proportion 
of mild or asymptomatic cases, 
contrary to the expectations of many 
experts. Professor Zahra Hasan and 
her team are working to understand 
why by examining the biology of 
both the virus and its human hosts. 
“The nature of the pandemic here 
in Pakistan has given rise to a lot 
of speculation,” Hasan said. “Why 
hasn’t it been worse? Is it because 
Pakistanis have a high level of 
immunity? Is it because our population 
is so young? We’re working to 
deliver rigorous explanations by 
analysing the genetic makeup and 
diversity of SARS-CoV-2 strains.” 
Hasan’s team has conducted whole 
genomic sequencing of the virus and 
has identified four different families 
of strains that were circulating in 
Pakistan at the start of the pandemic.
They are analysing these strains 
alongside more current strains to 
understand their variability and possible 
mutations in proteins – especially the 
spike protein or outer-coat proteins 
of the virus – that may cause different 
strains to be more infectious or deadly.
Biological differences between 
individuals can influence how they 
respond to viral infections. Researchers 
are studying genetic changes in 
blood samples gathered from mildly, 
moderately and critically ill COVID-19 
patients at the Aga Khan University 
Hospital in Karachi to identify 
biomarkers that lead to unfavourable 
outcomes or protection from the virus.
They are also collaborating with 
researchers at Nova University 
Lisbon to explore the role of 
protective antibody responses in the 
progression of COVID-19 in patients.
“The fact that we have a high incidence 
of mild disease is very noteworthy,” 
Hasan said. “It opens up the possibility 
that we could help deliver answers 
to fundamental questions about the 
virus that have global implications.”
The research team was able to 
jumpstart COVID-19 research as their 
SARS-CoV-2 sequencing builds on 
previous pathogen genomics work 
conducted alongside Professor Rumina 
Hasan. Their COVID-19 immunity 
work builds on the department’s 
ongoing research into tuberculosis 
and other infectious diseases.
The research team includes Rumina 
Hasan, Najia Ghanchi, Kiran Iqbal, Erum 
Khan, Asghar Nasir, Akbar Kanji and 
Safina Razzak from the Department of 
Pathology and Laboratory Medicine; 
Faisal Mahmood, Nosheen Nasir and 
Bushra Jamil from the Department of 
Medicine; Hani Abidi and Kulsoom 
Ghias from the Department of 
Biological and Biomedical Sciences; 
and Waqasuddin Khan from the 
Department of Paediatrics.
Research support has been provided 
by Health Security Partners in the 
United States, Pakistan’s Higher 
Education Commission and AKU’s 
University Research Council and 
Provost’s Academic Priorities Fund.
Casual attitude to 
COVID-19 in Pakistan 
is cause for concern
One in six Pakistani adults believes 
that they and their families are safe 
from COVID-19 even if they take no 
preventive measures, according to 
an online survey by AKU and The 
Chinese University of Hong Kong.
 
The survey was conducted in May 
2020 and gathered responses from 
1,406 Pakistanis and 1,715 Hong Kong 
residents. It found that Pakistanis 
were less concerned about COVID-
19’s complications and felt they were 
more likely to survive the virus than 
those surveyed in Hong Kong.
 
Forty-one per cent of Pakistanis rated 
COVID-19 symptoms as being severe 
or very severe, compared to 97 per 
cent of respondents in Hong Kong. 
Sixty-eight cent of Pakistanis said 
they had a high or very high chance of 
surviving the disease against 36 per 
cent of respondents in Hong Kong. 
Pakistanis were also less likely to seek 
out information on preventive measures 
and how to detect COVID-19 symptoms 
than their counterparts in Hong Kong. 
“The relatively casual attitude of 
literate Pakistanis toward COVID-19 
is concerning,” said AKU Professor 
and Associate Vice Provost for 
Research Fauziah Rabbani, the 
study’s principal investigator.
 
Compared to Hong Kong residents, 
Pakistanis were more trusting of 
government information sources. 
Nearly eight out of ten Pakistanis 
rated government information 
as being reliable or very reliable 
compared with just 16 per cent 
of people in Hong Kong.  
 
“In Hong Kong citizens took charge 
of the pandemic as they didn’t trust 
the government,” Dr Rabbani said. 
“Pakistanis are fortunate to have 
proactive government campaigns about 
mask use and physical distancing 
but have been relatively reluctant 
to adopt preventive measures.”
 
The survey also found evidence that 
Pakistani men and women responded 
to the pandemic differently. Despite 
a government-imposed lockdown, 
only 71 per cent of men said they 
avoided going out, compared to 87 
per cent of women. Sixty-two per 
cent of women reported experiencing 
symptoms of anxiety, compared to 
50 per cent of men. Men in Pakistan 
preferred to acquire information 
about the pandemic from their family 
and friends, while women viewed 
information from doctors as being 
more reliable. In both countries, three-
quarters of respondents said they were 
avoiding going to hospitals or clinics.
 
Drs Adeel Abid, Hania Shahzad,  
Hyder Ali Khan, Suneel Piryani and  
Ms Areeba Raza Khan contributed to 
the study.
University 
updates
AKU continues to strive to 
achieve its mission of solving the 
developing world’s most pressing 
problems by piloting and patenting 
new technologies, publishing 
groundbreaking studies in landmark 
journals, launching new centres 
for research and by continuing 
to invest in its infrastructure 
for knowledge generation.  
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The University’s Technology Innovation 
Support Centre (TISC) works with 
faculty and staff to create new 
technologies that can help to solve a 
wide range of problems. The Centre has 
either led or facilitated the development 
of the following technologies.
Multipurpose scope 
Despite significant technological 
advances, healthcare professionals 
continue to use multiple bulky and 
expensive devices to examine 
different parts of the human body. For 
example, dermascopes, otoscopes, 
ophthalmoscopes, otolaryngoscopes 
and dental scopes are used for 
examining skin, ears, eyes, nose, 
throat, teeth and more. Traditional 
devices also lack the ability to 
capture and share images.
To overcome these problems, AKU 
has developed a scope with different 
end-points that attach to a mobile 
phone’s camera. The probes turn the 
camera into a multipurpose scope 
that can be used to examine and 
capture images of the skin, ears, 
eyes, throat, nose and oral cavity.
An accompanying app uses artificial 
intelligence technology to analyse the 
images. The app also enables image 
sharing, which can help boost access 
to healthcare in remote areas where 
specialists are not easily accessible. 
The University has been issued a 
U.S. patent for this technology.
A clinical trial of the device is expected 
to begin by the end of 2020. Pilot 
studies will also be conducted in 
remote, rural regions of Central Asia.
AKU innovation 
delivers 
problem-solving 
technologies
Portable emergency ventilator
A portable, low-cost emergency 
ventilator developed by TISC is currently 
undergoing clinical trials. Unlike 
traditional bag-valve masks, which are 
manually pumped and can be difficult 
to use properly, the device is powered 
by a motor. Briefcase-sized, it is small 
enough for use in ambulances. It can 
also be used on hospital patients 
waiting for a traditional ventilator.   
Researchers have developed and 
patented several new technologies 
3D-printed nasal swabs
Nasal swabs are used to capture the 
sample needed to test individuals for 
COVID-19. 3D printing these swabs 
in Pakistan can help lower the cost of 
testing while supporting the country’s 
ability to conduct large numbers of 
tests (Pakistan is currently reliant on 
imported nasal swabs, which are in 
high demand around the world). TISC 
is manufacturing swabs using the 
University’s 3D printing facilities, and 
has completed a clinical trial which 
found that they are as safe, user-friendly 
and effective as existing swabs. AKU 
plans to seek regulatory approval that 
would allow it to market the swabs 
to other institutions in Pakistan.
CoronaCheck self-screening app
CoronaCheck is a mobile phone 
app that enables users to easily and 
safely evaluate whether they require a 
COVID-19 test by answering a series 
of questions regarding their health. 
CoronaCheck can help ensure that 
people who need testing get it, while 
also reducing unnecessary hospital 
visits and tests. The app is available 
to the public in Pakistan, Tajikistan, 
Tanzania, Kenya and Mozambique. It 
has helped more than 71,000 users. 
Telemedicine mobile phone app
Elaj Asaan, or Easy Treatment, is 
a mobile phone teleconsultation 
app developed in collaboration 
with the Aga Khan Health Service, 
Pakistan (AKHS,P). It allows patients, 
including in rural areas, to consult 
a doctor without having to travel to 
a healthcare facility. The app also 
makes it possible to securely maintain 
and share medical records, allows 
patients to pay for services through 
the app and provides patients with the 
opportunity to provide feedback on 
their consultation. Available in Pakistan 
through AKHS,P, the application will also 
be launched in Kenya and Tanzania.
UV-light disinfection device
The Aga Khan University Hospital, 
Nairobi, developed a device that uses 
ultraviolet light to disinfect spaces 
within the hospital, from offices to 
operating rooms. The Hospital uses 
the device on a regular basis. 
Patented tray to reduce 
surgical error
The misplacement of surgical 
instruments and medical supplies 
such as scissors and gauze during 
surgeries can lead to problems that 
endanger patient safety. The University 
has been issued a U.S. patent for a 
surgical tray that uses image processing 
technology to detect when instruments 
are removed from and placed back onto 
a tray, helping surgeons and support 
staff to keep track of vital equipment. 
A clinical trial to test the performance 
of the device will be launched soon. 
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Five new AKU research centres 
will deliver new knowledge in fields 
crucial to the health and well-being 
of the people of Asia and Africa. 
Cancer Centre
Cancer cases in Sub-Saharan Africa 
are surging, as western diets and 
lifestyles become more common and 
life expectancy increases. AKU’s new 
Cancer Centre in Nairobi aims to be a 
leader in the fight against the disease. 
It will combine innovative research 
with high-quality clinical care, train 
badly needed specialists and promote 
prevention and early detection. 
Today, with Africa accounting for just 2 
per cent of cancer clinical trials, doctors 
must prescribe cancer drugs that have 
never been rigorously tested in African 
populations. AKU will help to change 
that as one of the only institutions 
in Sub-Saharan Africa to meet 
U.S. Food and Drug Administration 
requirements for conducting clinical 
trials. The Centre will include a Centre 
for Women’s Cancer, which will 
conduct research on cancers that are 
especially common among African 
women, such as triple-negative breast 
cancer. It will also be well positioned 
to test novel therapies developed 
by AKU’s Centre for Regenerative 
Medicine and Stem Cell Research. 
The Centre is led by Founding Director 
Mansoor Saleh, who was previously 
Professor of Medicine and Pathology 
at the University of Alabama at 
Birmingham (UAB) and Director of 
the Phase I Programme of UAB’s 
Comprehensive Cancer Center.
Institute for Global Health 
and Development 
The Institute for Global Health 
and Development champions 
interdisciplinary research and cross-
sectoral action on major global health 
challenges, and seeks to contribute 
to the achievement of health-related 
Sustainable Development Goals.
The Institute advances its mission 
through partnerships with its 
New research 
centres will drive 
knowledge creation
sister agencies of the Aga Khan 
Development Network and leading 
organisations worldwide. 
With extensive reach in South and 
Central Asia and Africa, the Institute 
comprises a network of leading scholars 
delivering research findings from state-
of-the-art laboratories and extensive 
field sites in low-income urban and rural 
communities. Its efforts are focused on 
three areas within the broad context of 
health and health-related Sustainable 
Development Goals: climate change, 
urban development and health; gender 
inequality and health; and nutrition, 
food security and agriculture.
The Institute seeks to stimulate 
and elevate the scholarship around 
global health and development to 
tackle “wicked” problems affecting 
low- and middle-income countries. 
Based in Karachi, the Institute is led by 
Founding Director Professor Zulfiqar 
Bhutta, a globally renowned, award-
winning researcher in the field of 
maternal and child health, a member 
of the U.S. National Academy of 
Medicine and a Fellow of the Royal 
Society of the United Kingdom.  
The centres will advance knowledge 
regarding cancer, the brain, global 
health, emergency medicine, global 
surgery and more  
Centre of Excellence in 
Trauma and Emergencies
The primary goal of the Centre is to 
improve health outcomes for individuals 
and populations affected by trauma and 
emergencies, which account for more 
than half of the total burden of disease 
in low- and middle-income countries. 
Trauma and emergencies include 
motor vehicle crashes, humanitarian 
crises, disasters due to climate change 
and epidemics. Already, the Centre is 
leading a collaborative effort to train 
10 million Pakistanis over 10 years in 
cardiopulmonary resuscitation and 
bleeding control, an initiative that 
could help to save numerous lives.
Research will be a core component 
of the work of the Centre, which aims 
to establish a data capture system in 
multiple hospitals in Pakistan, launch 
a trauma and emergency medicine 
research fellowship, and publish 
a growing number of articles each 
year. Based in Karachi, the Centre 
is led by Founding Director Junaid 
Razzak, the 2020 recipient of the 
Presidential Lifetime Achievement 
Award from the U.S.-based Society 
for Academic Emergency Medicine’s 
Global Emergency Medicine Academy.
Centre for Global Surgery
An estimated 11 per cent of all deaths 
globally could be averted with timely 
access to surgical care. AKU’s new 
Centre for Global Surgery will work 
to expand access to high-quality 
surgery in low-income countries by 
training healthcare professionals in 
rural areas, developing standards and 
guidelines for surgical personnel and 
facilities in low-resource settings and 
advocating for government policies that 
support increased access to surgery. 
The Centre will engage in research 
that can inform efforts to improve 
surgical care in marginalised areas. 
Research projects may range from 
studies to determine surgical capacity 
in a given region to evaluations of 
interventions designed to improve 
surgical outcomes. Already, the Centre 
has undertaken a survey of hospitals 
across Pakistan that revealed there are 
multiple underappreciated challenges 
to the delivery of surgical care. The 
Centre is based in Karachi and is led 
by Associate Professor Sadaf Khan, 
an experienced general and colorectal 
surgeon who is also Associate Dean 
of Undergraduate Medical Education.
Brain and Mind Institute
Mental illness has risen to the top of 
the list of threats to the people and 
communities served by AKU. Children 
and young people are especially 
vulnerable, with large proportions of 
the population already suffering the 
lifelong consequences of inaction.
The Brain and Mind Institute will take an 
interdisciplinary approach to improving 
mental health, with an emphasis on 
aiding high-risk populations, including 
children, youth and women.
Bridging the fields of medicine and 
nursing, public health, women’s health, 
neuroscience, biology, psychiatry, 
psychology and the social sciences, 
the Institute will offer a platform for the 
study of a wide range of brain-related 
health conditions and the relationship 
between mental and physical illness. 
Based in Nairobi, the Institute is led 
by Founding Director Zul Merali, who 
is Professor Emeritus at the University 
of Ottawa’s Faculty of Medicine and 
Faculty of Social Sciences and was 
previously Founder and Scientific 
Director of the Canadian Depression 
Research and Intervention Network. 
AKU’s cancer clinical 
trials will bring new 
treatments and hope to 
patients in East Africa.
INSTITUTIONAL BIOSAFETY 
COMMITTEE
The Institutional Biosafety Committee 
(IBC) continues to work to ensure that 
the highest level of biosafety standards 
is followed. From January 2019 through 
September 2020, the Committee 
reviewed 237 project proposals and 
material transfer agreements. IBC also 
initiated a biosafety training programme 
for staff based on the American 
Society for Microbiology curriculum.
In response to the COVID-19 pandemic, 
IBC and the Research Office developed 
standard operating procedures that 
allowed laboratory and field activity 
to resume while protecting health 
and safety. As part of its efforts, IBC 
oversaw fit testing of N95 masks and 
training in donning and doffing of 
personal protective equipment. It also 
worked with the University Hospital 
pharmacy to manufacture a disinfectant 
for N-95 masks, as disinfectant was 
in short supply during the country-
wide lock down in Pakistan. 
Research 
facilities, oversight 
and ethics
SYMPOSIUM ON STEM CELL 
SCIENCE AND ETHICS
Stem cell research and regenerative 
medicine have the potential to alleviate 
suffering for millions of people, which 
is why AKU has established a Centre 
for Regenerative Medicine and Stem 
Cell Research at its Karachi campus 
with the support of the University of 
California, San Francisco. Yet these 
fields raise complex ethical challenges. 
To advance understanding of such 
issues in the context of a pluralistic 
world, the University organised a 
Symposium on Stem Cell Science, 
Regenerative Medicine, Ethics and 
Society together with NOVA University 
Lisbon in June 2019. The event featured 
leading scientists, ethicists, lawyers 
and scholars of religion from Europe, 
North America, the Middle East and 
Asia. Discussions covered experimental 
models of neurodegenerative 
diseases, bioethics in the context of 
Germany’s Muslim minority, the rise of 
unproven stem cell therapies, human-
animal chimeras and much more.
ANIMAL RESEARCH FACILITY
The Animal Research Facility on AKU’s 
Stadium Road campus is fully functional 
and meets international standards for 
small animal research laboratories. At 
present, the facility is equipped to work 
on rabbits, guinea pigs, rats and mice; 
has individually ventilated cages for 
immune-deficient animals, as required 
for stem cell transplantation studies; 
and has a dedicated procedure room 
where anaesthesia and surgery can be 
performed. The University is seeking 
international accreditation of the facility.
 
The facility was closed during the 
first COVID-19 peak in Pakistan to 
minimise transmission risks as multiple 
animal species were reported to be 
susceptible to SARS-CoV-2. Standard 
procedures were developed for safe 
conduct of animal-based research 
and activities have since resumed. 
The Ethics Committee for Animal Care 
and Use and the Research Office 
organised a virtual training workshop 
on the Principles of Laboratory 
Animal Science in September 
2020, which was well attended by 
participants from across Pakistan as 
well as Saudi Arabia and the US.  
JUMA RESEARCH LABORATORY
Twenty-six projects are underway in the 
Juma Research Laboratory’s Biosafety 
Level 2 lab. These involve research in 
the fields of immunohistochemistry, cell 
and molecular biology, bacteriology, 
virology, parasitology, genetics, 
cancer and tissue banking, with 
support from national and international 
grants. The Laboratory is also 
considering establishing a Biosafety 
Level 3 COVID-19 biorepository.  
The Laboratory is now equipped with 
a state-of-the-art next generation 
sequencer, MiSeq, from Illumina.
It is supported by technology for 
whole genome sequencing – a Qubit 
Fluorometer, Veriti Thermal Cycler, Palm 
Centrifuge and Vortex Genie. During 
lockdown, Laboratory staff continued 
working to properly maintain equipment 
and consumables and safeguard 
bio-samples. Once the lockdown 
eased, the Laboratory resumed 
normal operations in accordance with 
standard operating procedures. 
NEW ENGLAND JOURNAL OF 
MEDICINE: RANDOMISED TRIAL OF 
AMOXICILLIN FOR PNEUMONIA IN 
PAKISTAN 
A double-blind, randomized, placebo-
controlled non-inferiority trial was 
conducted involving children at primary 
health care centers in low-income 
communities in Karachi, Pakistan. 
Children who were 2 to 59 months 
of age and who met WHO criteria for 
non-severe pneumonia with tachypnea 
were randomly assigned to a 3-day 
course of a suspension of amoxicillin 
(the active control) of 50 mg per milliliter 
or matched volume of placebo (the test 
regimen), according to WHO weight 
bands (500 mg every 12 hours for a 
weight of 4 to <10 kg, 1000 mg every 
12 hours for a weight of 10 to <14 
kg, or 1500 mg every 12 hours for a 
weight of 14 to <20 kg). The primary 
outcome was treatment failure during 
the 3-day course of amoxicillin or 
placebo. From November 9, 2014, 
through November 30, 2017, a total of 
4002 children underwent randomization 
(1999 in the placebo group and 2003 
in the amoxicillin group). The incidence 
of treatment failure was 4.9% among 
placebo recipients (95 of 1927 children) 
and 2.6% among amoxicillin recipients 
(51 of 1929 children, between-group 
difference 2.3 percentage points; 95% 
confidence interval [CI], 0.9 to 3.7). The 
presence of fever and wheeze predicted 
treatment failure. The number needed 
to treat to prevent one treatment failure 
was 44 (95% CI, 31 to 80). One patient 
(<0.1%) in each group died. Relapse 
occurred in 40 children (2.2%) in the 
placebo group and in 58 children (3.1%) 
in the amoxicillin group. Among children 
younger than 5 years of age with 
non-severe pneumonia, the frequency 
of treatment failure was higher in the 
placebo group than in the amoxicillin 
group, a difference that did not meet 
the non-inferiority margin for placebo.
Fyezah Jehan, Imran Nisar, Salima 
Kerai, Benazir Balouch, Nick Brown, 
Najeeb Rahman, Arjumand Rizvi, Yasir 
Shafiq, and Anita K.M. Zaidi (2020). 
Randomised Trial of Amoxicillin for 
Pneumonia in Pakistan. New England 
Journal of Medicine 2020; 383:24-34.
High impact 
publications
FRONTIERS IN ONCOLOGY: LACK OF 
ANDROGEN RECEPTOR SELECTS 
FOR BASAL-LIKE PHENOTYPE
Androgen receptor (AR) has emerged 
as a significant favorable prognostic 
indicator in estrogen-receptor 
expressing (ER+) breast cancer (BCa). 
However, its clinical and biological 
relevance in triple negative breast 
cancer (TNBC) and association with 
cancer stem cell (CSC) markers 
remain ambiguous. We examined the 
immunohistochemical expression of AR 
in a cohort of stage I–III TNBC cases 
(n=197) with long-term clinical follow-up 
data (mean follow-up = 53.6 months). 
Significance of AR expression was 
correlated with prognostic biomarkers 
including cancer stem cell markers 
(CD44, CD24, and ALDH1), basal 
markers (CK5, CK14, and nestin), 
proliferation marker (ki-67), apoptotic 
marker (Bcl-2), and COX-2. Expression 
of CK5 and nestin was used for the 
categorization of TNBC into basal 
(TN, CK5+, and/or nestin+) and non-
basal (TN, CK5−, and/or nestin−) 
phenotypes, and Kaplan–Meier curves 
were used for estimation of overall 
survival and breast cancer-specific 
survival (BCSS). Assessment of AR and 
basal markers identified biologically 
and clinically distinct subgroups of 
TNBC. Expression of AR defined a 
low-risk TNBC subgroup associated 
with improved overall survival, whereas 
expression of basal markers (CK5 and 
nestin) identified a high-risk subgroup 
associated with adverse BCSS. 
Integration of immunohistochemical 
analysis of AR and basal biomarkers 
to the assessment of TNBC tumors is 
expected to improve the prognostication 
of an otherwise heterogeneous disease.
Nazia Riaz, Romana Idress, Sadia 
Habib and El-Nasir Lalani (2020). 
Lack of androgen receptor selects 
for basal-like phenotype and is a 
predictor of poor clinical outcome in
non-metastatic triple negative 
breast cancer. Frontiers in 
Oncology 2020; 10:1083.
THE BMJ: COVID-19 RISK AND 
RESPONSES IN SOUTH ASIA  
From what initially seemed like a 
localised outbreak in Hubei province 
of China in December 2019, it rapidly 
became clear that SARS-CoV-2 had 
pandemic potential. The number of 
deaths from COVID-19 in Italy now 
exceeds those reported from China, and 
the outbreak in Iran may have seeded 
cases in Pakistan and Afghanistan. 
The number of reported cases in South 
Asia remains relatively low, however, 
and the response patchy. By 24 
March, authorities in the South Asian 
Association for Regional Cooperation 
(SAARC), which comprises India, 
Pakistan, Bangladesh, Nepal, Sri Lanka, 
Maldives, Bhutan, and Afghanistan, 
had reported just 1536 confirmed 
cases and 22 deaths. Although all 
countries took individual actions, it 
took the collective political leadership 
of SAARC almost two months to put 
aside political differences and meet 
to discuss the dangers to the region 
posed by COVID-19. The actions 
of individual countries in SAARC 
have varied. Although the potential 
economic and social consequences 
of such measures could be huge, 
allowing the counterfactual reality of 
continued regular activities and mass 
congregations would be extremely 
unwise. Testing at scale is limited, 
focusing mainly on individuals 
arriving from affected countries and 
their immediate contacts. The only 
effective intervention implemented 
is that all countries in the region 
have drastically reduced or stopped 
air travel and imposed quarantine 
protocols on people arriving by road 
or air from countries with COVID-19 
transmission. However, facilities for 
screening and quarantine remain 
limited and of questionable quality.
Zulfiqar A. Bhutta, Buddha Basnyat, 
Samir Saha, Ramanan Laxminarayan 
(2020). Covid-19 Risk and Responses 
in South Asia. British Medical 
Journal 2020; 368:m1190.
LANCET GLOBAL HEALTH: 
PERFORMANCE OF LATE 
PREGNANCY BIOMETRY FOR 
GESTATIONAL AGE DATING 
This prospective, population-based, 
cohort study was done in three LMICs 
(Bangladesh, Pakistan, and Tanzania) 
participating in the WHO Alliance 
for Maternal and Newborn Health 
Improvement study. Women carrying 
a live singleton fetus dated by crown-
rump length (CRL) measurements 
between 8+0-14+6 weeks of gestation, 
who were willing to return for two 
additional ultrasound scans, and who 
planned on delivering in the study area 
were enrolled in the study. Participants 
underwent ultrasonography at 24+0-
29+6 weeks and at 30+0-36+6 weeks’ 
gestation. Statistical modelling was 
done to develop new gestational 
age prediction formulas for third 
trimester ultrasonography in LMICs. 
With standard dating formulas, late 
pregnancy ultrasound at 24+0-29+6 
weeks’ gestation was accurate to within 
approximately plus or minus 2 weeks 
of the gold standard CRL measurement 
of gestational age, and late pregnancy 
ultrasound was accurate to within 
±3 weeks of the CRL measurement 
at 30+0-36+6 weeks’ gestation. By 
use of a novel parsimonious model 
formula that combined TCD with 
femur length, gestational age at the 
24+0-29+6-week ultrasound scan 
was estimated to within ±10.5 days of 
the CRL measurement and estimated 
to within ±15.1 days of the CRL 
measurement at the 30+0-36+6-week 
ultrasound scan. Similar results were 
observed in infants who were small-
for-gestational-age. Incorporation of 
TCD and the use of new formulas in 
late pregnancy ultrasound scans could 
improve the accuracy of gestational 
age estimation in both appropriate-
for-gestational-age and small-for-
gestational-age infants in LMICs. 
Validation of this new formula in other 
LMIC populations is needed to establish 
whether the accuracy of the late 
pregnancy ultrasound can be narrowed 
to within approximately 2 weeks.
The WHO Alliance for Maternal and 
Newborn Health Improvement Late 
Pregnancy Dating Study Group. Nasir 
et al. Performance of late pregnancy 
biometry for gestational age dating 
in low-income and middle-income 
countries: a prospective, multi-country, 
population-based cohort study 
from the WHO Alliance for Maternal 
and Newborn Health Improvement 
(AMANHI) Study Group. Lancet 
Global Health 2020; 8(4):e545-e554.
LANCET INFECTIOUS DISEASES: 
HIV INFECTION PREDOMINANTLY 
AFFECTING CHILDREN IN SINDH, 
PAKISTAN 
In this cross-sectional study in April 
2019, the outbreak response from 
the government, academia, and 
UN agencies in Larkana, Sindh, 
Pakistan was reviewed. For children 
who registered for HIV care, clinical 
history of previous injections and 
blood transfusions, HIV disease stage, 
hepatitis B and hepatitis C status, 
and CD4 count was abstracted from 
clinical records from Sindh AIDS Control 
Program HIV Clinic (Shaikh Zayed 
Children’s Hospital, Larkana, Pakistan) 
and analysed using percentages, chi(2) 
tests, and weight-for-age Z scores. 
Between April 24, and July 15, 2019, 
31 239 individuals underwent HIV 
testing, of whom 930 (3%) tested 
positive for HIV. Of these, 763 (82%) 
were younger than 16 years and 604 
(79%) of these were aged 5 years and 
below. Estimated HIV prevalence was 
3% overall; 7% (283 of 3803) in children 
aged 0-2 years, 6% (321 of 5412) in 
children aged 3-5 years, and 1% (148 
of 11 251) in adults aged 16-49 years. 
Of the 591 children who registered for 
HIV care, 478 (81%) were 5 years or 
younger, 379 (64%) were boys, and 315 
(53%) of 590 had a weight-for-age Z 
score of -3.2. Prevalence of hepatitis 
B surface antigen was 8% (48 of 574) 
and hepatitis C antibody positivity was 
3% (15 of 574). Of children whose 
mothers tested for HIV, only 39 (11%) 
of 371 had HIV-positive mothers. 
Most children (404 [89%] of 453) 
reported multiple previous injections 
and 40 (9%) of 453 reported blood 
transfusions. The outbreak was heavily 
skewed towards children younger 
than 5 years, with a predominance of 
boys. Epidemiological and molecular 
studies are needed to understand 
the full extent of the outbreak and its 
drivers to guide HIV control strategies.
Mir, F., Mahmood, F., Siddiqui, 
A. R., Baqi, S., Abidi, S. H., et al. 
(2020). HIV infection predominantly 
affecting children in Sindh, Pakistan, 
2019: a cross-sectional study of 
an outbreak. Lancet Infectious 
Diseases  2020; 20(3), 362-370.
BMJ GLOBAL HEALTH: GLOBAL 
STRATEGIES AND LOCAL 
IMPLEMENTATION OF HEALTH AND 
HEALTH-RELATED SDGS 
Evidence on early achievements, 
challenges and opportunities would 
help low-income and middle-
income countries (LMICs) accelerate 
implementation of health and health-
related sustainable development goals 
(HHSDGs). Consultative meetings 
were conducted during 2018–2019 
that involved 15 countries across five 
regions to determine the status of 
implementation of HHSDGs. Almost 
120 representatives from health and 
non-health sectors participated. The 
assessment relied on a multidomain 
analytical framework drawing 
on existing public health policy 
frameworks. During the first 5 years 
of the sustainable development goals 
(SDGs) era, participating LMICs from 
South and Central Asia, East Africa 
and Latin America demonstrated 
growing political commitment to 
HHSDGs, with augmentation of 
multisectoral institutional arrangements, 
strengthening of monitoring systems 
and engagement of development 
partners. On the other hand, there 
has been limited involvement of civic 
society representatives and academia, 
relatively few capacity development 
initiatives were in place, a well-
crafted communication strategy was 
missing, and there is limited evidence 
of additional domestic financing for 
implementing HHSDGs. While the 
momentum towards universal health 
coverage is notable, explicit linkages 
with non-health SDGs and integrated 
multisectoral implementation strategies 
are lacking. The study offers messages 
to LMICs that would allow for a full 
decade of accelerated implementation 
of HHSDGs, and points to the need for 
more implementation research in each 
domain and for testing interventions 
that are likely to work before scale-up.
Sameen Siddiqi, Wafa Aftab, Fahad 
Javaid Siddiqui, Luis Huicho, Roman 
Mogilevskii, Peter Friberg, Johanna 
Lindgren-Garcia, Sara Causevic, Anil 
Khamis, Mashal Murad Shah, Zulfiqar 
Ahmed Bhutta (2020). Global strategies 
and local implementation of health 
and health-related SDGs: lessons from 
consultation in countries across five 
regions. BMJ Global Health; 5:e002859.
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